BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 96 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $159,000 | -30.9% | 3,005 | -20.0% | 0.00% | – |
Q2 2020 | $230,000 | -28.6% | 3,755 | -34.1% | 0.00% | – |
Q1 2020 | $322,000 | -68.3% | 5,695 | -68.1% | 0.00% | – |
Q4 2019 | $1,016,000 | +19.1% | 17,843 | +11.9% | 0.00% | – |
Q3 2019 | $853,000 | +20.0% | 15,943 | +33.9% | 0.00% | – |
Q2 2019 | $711,000 | +32.9% | 11,910 | +38.7% | 0.00% | – |
Q1 2019 | $535,000 | +133.6% | 8,585 | +126.8% | 0.00% | – |
Q4 2018 | $229,000 | +19.3% | 3,785 | +15.5% | 0.00% | – |
Q3 2018 | $192,000 | +61.3% | 3,278 | +23.9% | 0.00% | – |
Q2 2018 | $119,000 | -39.6% | 2,645 | -40.3% | 0.00% | – |
Q1 2018 | $197,000 | -19.3% | 4,434 | -21.4% | 0.00% | – |
Q4 2017 | $244,000 | -17.6% | 5,642 | -11.3% | 0.00% | – |
Q3 2017 | $296,000 | -14.0% | 6,364 | -8.6% | 0.00% | – |
Q2 2017 | $344,000 | +1.2% | 6,961 | +12.2% | 0.00% | – |
Q1 2017 | $340,000 | -12.4% | 6,204 | -10.9% | 0.00% | – |
Q4 2016 | $388,000 | +47.5% | 6,965 | +21.0% | 0.00% | – |
Q3 2016 | $263,000 | +18.5% | 5,758 | +3.5% | 0.00% | – |
Q2 2016 | $222,000 | +19.4% | 5,562 | +4.1% | 0.00% | – |
Q1 2016 | $186,000 | -4.1% | 5,343 | +18.7% | 0.00% | – |
Q4 2015 | $194,000 | -17.1% | 4,502 | -16.5% | 0.00% | – |
Q3 2015 | $234,000 | +81.4% | 5,391 | +114.9% | 0.00% | – |
Q2 2015 | $129,000 | +2050.0% | 2,509 | +1478.0% | 0.00% | – |
Q1 2015 | $6,000 | -33.3% | 159 | -32.3% | 0.00% | – |
Q4 2014 | $9,000 | – | 235 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|